Sign up to save your podcasts
Or
Share Spotlight: How The FTC Could Hurt The Future Of Cancer Research
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Spotlight: How The FTC Could Hurt The Future Of Cancer Research
The Federal Trade Commission is taking action to block a biotech merger that will ultimately hinder the fight against cancer. Is it time to abolish this destructive agency? Steve Forbes on how this government body is doing more harm than good and on why the White House and Congress should act now.
Steve Forbes shares his What’s Ahead Spotlights each Tuesday, Thursday and Friday.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
View all episodes
By Forbes
4.8
494494 ratings
The Federal Trade Commission is taking action to block a biotech merger that will ultimately hinder the fight against cancer. Is it time to abolish this destructive agency? Steve Forbes on how this government body is doing more harm than good and on why the White House and Congress should act now.
Steve Forbes shares his What’s Ahead Spotlights each Tuesday, Thursday and Friday.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
More shows like Steve Forbes: What's Ahead
View all
WSJ What’s News
4,364 Listeners
WSJ Your Money Briefing
1,756 Listeners
WEALTHTRACK
266 Listeners
Investing Insights
497 Listeners
Bold Names
1,438 Listeners
Schwab Market Update Audio
320 Listeners
Newt's World
6,580 Listeners
The Journal.
5,950 Listeners
Squawk on the Street
600 Listeners
Barron's Streetwise
1,546 Listeners
Larry Kudlow Show
459 Listeners
WSJ Opinion: Free Expression
596 Listeners
Forbes Daily Briefing
12 Listeners
Forbes Newsroom
3 Listeners
Forbes Talks
4 Listeners
Kudlow
128 Listeners
Charles Payne's Unstoppable Prosperity Podcast
138 Listeners
All Things with Kim Strassel
140 Listeners